In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...

Cathie Wood’s ARK Invest’s largest purchase by value during July 13-17 was Elon Musk’s Space Exploration Technologies (SPCX), ...

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted ...

In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.34, indicating a +1.21% shift from the ...

Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.